BIOGEN INC. - COMMON S
156.83
26-November-24 11:01:42
15 minutes delayed
Stocks
-1.07
-0.68%
Today's range
156.38 - 160.00
ISIN
N/A
Source
NASDAQ
-
26 Jan 2023 18:30:00 By Nasdaq GlobeNewswire
-
Biogen Names Priya Singhal as Executive Vice President, Head of Development
05 Jan 2023 07:30:00 By Nasdaq GlobeNewswire
-
04 Jan 2023 07:30:00 By Nasdaq GlobeNewswire
-
19 Dec 2022 07:30:00 By Nasdaq GlobeNewswire
-
09 Dec 2022 07:30:00 By Nasdaq GlobeNewswire
-
05 Dec 2022 07:30:00 By Nasdaq GlobeNewswire
-
Biogen Names Christopher Viehbacher President and Chief Executive Officer
10 Nov 2022 07:30:01 By Nasdaq GlobeNewswire
-
26 Oct 2022 06:05:00 By Nasdaq GlobeNewswire
-
26 Oct 2022 06:02:00 By Nasdaq GlobeNewswire
-
Biogen Announces FDA’s 3-Month Extension of Review Period for the New Drug Application for Tofersen
17 Oct 2022 07:30:10 By Nasdaq GlobeNewswire
-
30 Sep 2022 07:00:00 By Nasdaq GlobeNewswire
-
21 Sep 2022 17:15:12 By Nasdaq GlobeNewswire
-
07 Sep 2022 17:45:26 By Nasdaq GlobeNewswire
-
28 Jul 2022 07:30:00 By Nasdaq GlobeNewswire
-
26 Jul 2022 07:30:02 By Nasdaq GlobeNewswire
-
European Patent Office Grants Patent Related to TECFIDERA® (Dimethyl Fumarate)
21 Jun 2022 06:37:05 By Nasdaq GlobeNewswire
-
15 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
The Biogen Foundation and Community Lab Celebrates 20 Years of Serving our Communities
14 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
06 Jun 2022 07:30:00 By Nasdaq GlobeNewswire
-
03 Jun 2022 08:00:01 By Nasdaq GlobeNewswire